Načítá se...

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: A multicenter study

OBJECTIVES: Florbetapir F 18 PET can image amyloid-β (Aβ) aggregates in the brains of living subjects. We prospectively evaluated the prognostic utility of detecting Aβ pathology using florbetapir PET in subjects at risk for progressive cognitive decline. METHODS: A total of 151 subjects who previou...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Murali Doraiswamy, P., Sperling, Reisa A., Coleman, R. Edward, Johnson, Keith A., Reiman, Eric M., Davis, Mat D., Grundman, Michael, Sabbagh, Marwan N., Sadowsky, Carl H., Fleisher, Adam S., Carpenter, Alan, Clark, Christopher M., Joshi, Abhinay D., Mintun, Mark A., Skovronsky, Daniel M., Pontecorvo, Michael J.
Médium: Artigo
Jazyk:Inglês
Vydáno: Lippincott Williams & Wilkins 2012
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3468774/
https://ncbi.nlm.nih.gov/pubmed/22786606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182661f74
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!